SK280599B6 - Farmaceutický prostriedok s antimykotickým účinkom - Google Patents

Farmaceutický prostriedok s antimykotickým účinkom Download PDF

Info

Publication number
SK280599B6
SK280599B6 SK5953-90A SK595390A SK280599B6 SK 280599 B6 SK280599 B6 SK 280599B6 SK 595390 A SK595390 A SK 595390A SK 280599 B6 SK280599 B6 SK 280599B6
Authority
SK
Slovakia
Prior art keywords
weight
polyethylene glycol
pharmaceutical composition
preparation according
hydroxypoly
Prior art date
Application number
SK5953-90A
Other languages
English (en)
Slovak (sk)
Other versions
SK595390A3 (en
Inventor
Walter Fries
Original Assignee
Heinrich Mack Nachf.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heinrich Mack Nachf. filed Critical Heinrich Mack Nachf.
Publication of SK280599B6 publication Critical patent/SK280599B6/sk
Publication of SK595390A3 publication Critical patent/SK595390A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK5953-90A 1989-11-29 1990-11-29 Pharmaceutical composition with antimycotic activity SK595390A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3939492A DE3939492A1 (de) 1989-11-29 1989-11-29 Pharmazeutische zubereitungen

Publications (2)

Publication Number Publication Date
SK280599B6 true SK280599B6 (sk) 2000-04-10
SK595390A3 SK595390A3 (en) 2000-04-10

Family

ID=6394433

Family Applications (1)

Application Number Title Priority Date Filing Date
SK5953-90A SK595390A3 (en) 1989-11-29 1990-11-29 Pharmaceutical composition with antimycotic activity

Country Status (29)

Country Link
US (1) US5118698A (xx)
EP (1) EP0430149B1 (xx)
JP (1) JPH0660097B2 (xx)
KR (1) KR940000066B1 (xx)
CN (1) CN1035357C (xx)
AT (1) ATE102051T1 (xx)
AU (1) AU626480B2 (xx)
BR (1) BR9006025A (xx)
CA (1) CA2030911C (xx)
CY (1) CY1970A (xx)
CZ (1) CZ282898B6 (xx)
DE (2) DE3939492A1 (xx)
DK (1) DK0430149T3 (xx)
EG (1) EG19557A (xx)
ES (1) ES2062271T3 (xx)
FI (1) FI103713B1 (xx)
HK (1) HK216896A (xx)
HU (1) HU220867B1 (xx)
IE (1) IE64672B1 (xx)
IL (1) IL96450A (xx)
MX (1) MX23518A (xx)
MY (1) MY104540A (xx)
NO (1) NO180475C (xx)
NZ (1) NZ236255A (xx)
PT (1) PT96003B (xx)
RU (1) RU2038080C1 (xx)
SK (1) SK595390A3 (xx)
YU (1) YU227290A (xx)
ZA (1) ZA909549B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE164080T1 (de) * 1990-05-10 1998-04-15 Bechgaard Int Res Pharmazeutische zubereitung enthaltend n- glykofurole und n-äthylenglykole
US5397771A (en) * 1990-05-10 1995-03-14 Bechgaard International Research And Development A/S Pharmaceutical preparation
JP3485540B2 (ja) * 2000-12-28 2004-01-13 新日本製鐵株式会社 低騒音トランス
JP4057423B2 (ja) * 2001-02-28 2008-03-05 インターベツト・インターナシヨナル・ベー・ベー 注射用油中水型乳剤
PT1471887E (pt) 2002-02-04 2010-07-16 Elan Pharma Int Ltd ComposiãŽes de nanopartculas com lisozima como um estabilizador superficial
WO2004006959A1 (en) * 2002-07-16 2004-01-22 Elan Pharma International, Ltd Liquid dosage compositions of stable nanoparticulate active agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1196284A (en) * 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
GR79307B (xx) * 1982-06-09 1984-10-22 Pfizer
DK476385A (da) * 1984-10-19 1986-04-20 Schering Corp 1,3-bis(1h-1,2,4-triazol-1-yl)-2-flour-2-(2,4-difluorphenyl)propan, antifungale midler indeholdende denne forbindelse, og fremgangsmaade til fremstilling af denne forbindelse

Also Published As

Publication number Publication date
YU227290A (sh) 1993-10-20
PT96003B (pt) 1998-01-30
IE904282A1 (en) 1991-06-05
US5118698A (en) 1992-06-02
AU6706590A (en) 1991-08-08
PT96003A (pt) 1991-09-13
KR910009286A (ko) 1991-06-28
DK0430149T3 (da) 1994-03-28
CZ595390A3 (en) 1997-06-11
NO180475B (no) 1997-01-20
HU220867B1 (en) 2002-06-29
ES2062271T3 (es) 1994-12-16
HK216896A (en) 1996-12-27
FI905814A (fi) 1991-05-30
DE3939492A1 (de) 1991-06-06
EG19557A (en) 1997-08-31
EP0430149A2 (en) 1991-06-05
FI103713B (fi) 1999-08-31
RU2038080C1 (ru) 1995-06-27
CA2030911A1 (en) 1991-05-30
DE69007029T2 (de) 1994-06-09
ATE102051T1 (de) 1994-03-15
SK595390A3 (en) 2000-04-10
NO905106L (no) 1991-05-30
CN1052046A (zh) 1991-06-12
JPH0660097B2 (ja) 1994-08-10
CY1970A (en) 1997-09-05
DE69007029D1 (de) 1994-04-07
FI103713B1 (fi) 1999-08-31
MX23518A (es) 1993-04-01
CZ282898B6 (cs) 1997-11-12
KR940000066B1 (ko) 1994-01-05
CN1035357C (zh) 1997-07-09
IL96450A (en) 1994-10-21
ZA909549B (en) 1992-06-24
EP0430149B1 (en) 1994-03-02
NZ236255A (en) 1992-02-25
NO180475C (no) 1997-04-30
CA2030911C (en) 1995-02-07
FI905814A0 (fi) 1990-11-26
IE64672B1 (en) 1995-08-23
HUT57039A (en) 1991-11-28
MY104540A (en) 1994-04-30
JPH03176421A (ja) 1991-07-31
AU626480B2 (en) 1992-07-30
EP0430149A3 (en) 1991-09-25
BR9006025A (pt) 1991-09-24
NO905106D0 (no) 1990-11-26

Similar Documents

Publication Publication Date Title
EP0546018B1 (en) Pharmaceutical composition of florfenicol
EP2470178B1 (en) Antimycotic pharmaceutical composition
SK281558B6 (sk) Injikovateľná kompozícia na prípravu infúzneho roztoku obsahujúca deriváty skupiny taxánov
JPH0774162B2 (ja) 水銀含有防腐剤を安定化した眼炎治療薬
US11065265B2 (en) Compositions of fosaprepitant and methods of preparation
SK278929B6 (sk) Roztoky piroxikamu so zvýšenou stabilitou a bez úč
WO2011014541A1 (en) Stable formulations of azacitidine
SK280599B6 (sk) Farmaceutický prostriedok s antimykotickým účinkom
US5886018A (en) Pharmaceutical composition for parenteral administration containing an indole-carboxylic acid
KR100748252B1 (ko) 플로르페니콜 및 타이로신 함유 주사용 조성물
KR100548948B1 (ko) 플로르페니콜의 약제학적 조성물
EP3815677A1 (en) Stable veterinary composition comprising moxidectin and imidacloprid
KR100748251B1 (ko) 플로르페니콜 함유 주사용 조성물
HU183244B (en) Process for preparing stable solutions containing hydrogenated ergot alkaloids and salts thereof resp. and heparin
EP0508311A1 (en) Injectable compositions containing 2-oxindole-1-carboxamide derivatives
RU2278661C2 (ru) Противопаразитарное средство
JPS6193117A (ja) 副作用の軽減されたペネム型またはカルバペネム型抗生物質製剤
MXPA97006044A (en) Pharmaceutical composition for parenteral application, which contains an acidoindol-carboxil